Summary- Five year follow-up data show FOTIVDA® (tivozanib) patients up to 5X more likely to experience long-term PFS compared to Nexavar® (sorafenib)…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Generalized Myasthenia Gravis
-
-
AgrochemicalsArgenx
Argenx Snags First US. FDA Approval With Vyvgart (efgartigimod alfa-fcab) win in Generalized Myasthenia Gravis
by adminby adminSynopsis: VYVGART is the first-and-only FDA-approved neonatal Fc receptor blocker 68% of anti-acetylcholine receptor (AChR) antibody positive gMG patients treated with VYVGART…